Markel Operating Cash Flow decreased by 97.6% to $15.91M in Q1 2026 compared to the prior quarter. Year-over-year, this metric declined by 95.8%, from $376.19M to $15.91M. Over 4 years (FY 2021 to FY 2025), Operating Cash Flow shows an upward trend with a 5.0% CAGR. This decline may warrant attention — for this metric, higher values are generally preferred.
An increase indicates strong operational efficiency and cash generation, while a decrease may signal operational challenges or issues with working capital management.
This metric represents the total cash generated or consumed by a company's core business operations during a specific pe...
Standard across all industries; peers in the medical device and diagnostics sector typically maintain high conversion ratios of net income to operating cash flow.
net_cash_from_operating| Q2 '21 | Q3 '21 | Q4 '21 | Q1 '22 | Q2 '22 | Q3 '22 | Q4 '22 | Q1 '23 | Q2 '23 | Q3 '23 | Q4 '23 | Q1 '24 | Q2 '24 | Q3 '24 | Q4 '24 | Q1 '25 | Q2 '25 | Q3 '25 | Q4 '25 | Q1 '26 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Value | $495.05M | $809.27M | $651.63M | $414.87M | $506.12M | $959.28M | $829.17M | $284.18M | $724.44M | $955.66M | $822.53M | $630.65M | $578.63M | $890.78M | $493.95M | $376.19M | $504.40M | $1.22B | $662.19M | $15.91M |
| QoQ Change | — | +63.5% | -19.5% | -36.3% | +22.0% | +89.5% | -13.6% | -65.7% | +154.9% | +31.9% | -13.9% | -23.3% | -8.3% | +53.9% | -44.5% | -23.8% | +34.1% | +141.6% | -45.7% | -97.6% |
| YoY Change | — | — | — | — | +2.2% | +18.5% | +27.2% | -31.5% | +43.1% | -0.4% | -0.8% | +121.9% | -20.1% | -6.8% | -39.9% | -40.3% | -12.8% | +36.8% | +34.1% | -95.8% |